Gottlieb Reshapes FDA to Elevate Centers, Streamline Policymaking

In this ISSUE

Does the Pfizer Restructuring Make Sense?

FDA Opens Door to Importing Scarce and Costly Drugs

Enabling Cultural Change in Organizations

Top Story

Gottlieb Reshapes FDA to Elevate Centers, Streamline Policymaking

Scott Gottlieb is proposing to flatten out FDA's structure by having Center directors report directly to him, giving more authority to the agency's six product regulatory Centers and to the Office of Regulatory Affairs. Jill Wechsler reports.
… /Read more/

The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.

Explore now

Global Health

Roche's Marcus Gemuend: Access to Medicines in Sub-Saharan Africa

Marcus Gemuend, Roche's head of the Sub-Saharan African region, talks to Pharm Exec about the extensive programs the company is working on in the region, the barriers faced and the progress made
… /Read more/

Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.

Emerging Markets

The Diabetes Market in China

With China predicted to account for 48% of the global diabetes population by 2045, Jin Zhang looks at how the country's domestic pharma companies are faring in this treatment area
… /Read more/

A Framework for Successful Biopharma Launches Understanding the launch archetype and identifying critical success factors
On Demand

Learn more

Calendar

/ August 14–15: Publication Planning 2018 /

Philadelphia, PA

/ August 15–16: Reimbursement and Access 2018 /

Philadelphia, PA

/ August 20–22: Transparency and Aggregate Spend 2018 /

Washington, DA, PA

/ September 25–26: Finance and Accounting for Bioscience Companies /

Boston, MA

/ September 25–26: 4^th Annual Bio/Pharmaceutical Product Launch Summit /

Cambridge, MA

/ September 27: 3^rd Edition Drug Pricing Transparency Congress /

Philadelphia, PA

/ October 2–3: Advanced Therapies Commercialization Congress /

Amsterdam, The Netherlands

/ November 14–15: Commercial Data Insights 2018 /

Philadelphia, PA

/ November 14–15: 5^th Annual Global Compliance Congress for Life Sciences /

London, UK

/ November 28–29: Compliant Patient Support Programs Summit /

Chicago, IL

/ December 4–5: Managed Markets Compliance Congress 2018 /

Philadelphia, PA

/ December 5–6: Bio/Pharma Compliance Congress on Non-Promotional Activities /

Philadelphia, PA

Technology

Optimizing the Digital Opportunity in Biopharmaceutical R&D

If advanced technologies hold the key to at least some of the productivity issues R&D organizations need to overcome, Nicholas Lakin asks what are the best strategies and operating models for exploiting these aids to their fullest potential?
… /Read More/

Audio

Pharm Exec Podcast: Running a Successful Clinical-Stage Pharma Startup

In this episode, Jeffrey Nau, CEO of Oyster Point Pharma, a company developing commercial therapies dealing with parasympathetic pathways, talks about what it's like working on diseases, such as dry eye, that don't receive much media attention
… /Click here to listen/

Industry update

// Dr. Irach Taraporewala became the new CEO of NanoViricides (Shelton, CT). // Astellas Americas (Northbrook, IL) named Dr. Halit Bander as VP, Oncology, Medical Affairs; Moyra Knight as VP, Corporate Communications; and Maribeth Landwehr as Executive Director, Corporate Communications. // Adverum Biotechnologies (Menlo Park, CA) appointed Katherine Bock as Vice President, Investor Relations and Corporate Communications. // GreenLight Biosciences (Medford, MA) announced that Mick Messman has joined the company as Chief Commercial Officer. // Epizyme (Cambridge, MA) appointed Dr. Shefali Agarwal as Chief Medical Officer. // Soligenix (Princeton, NJ) appointed Mark Pearson, CEO of Altamont Pharmaceutical Holdings,to its Board of Directors. // PhaseBio Pharmaceuticals (Malvern, PA) announced the appointment of Caroline M. Loewy to its Board of Directors. // lbireo Pharma (Boston, MA) appointed Dr. Patrick Horn as Chief Medical Officer. //

advertise with us / print subscribe / digital subscribe / visit pharmexec.com